VREX
Varex Imaging Corp
NASDAQ · Healthcare · Medical - Devices · US
$18.49
−0.27%Year over year
Reported trailing growth
- Revenue
- +5.3%
- EBITDA
- +1110.5%
- EBIT
- +297.8%
- EPS
- +116.3%
- Free cash flow
- —
- Operating cash flow
- -81.1%
Forward estimates
Based on analyst estimates
- Revenue
- +3.3%
- EBITDA
- +45.8%
- EPS
- +73.3%
Three-year CAGR
- Revenue
- -0.6%
- EBITDA
- -68.7%
- EBIT
- —
- Net income
- -47.4%
- EPS
- -45.3%
- Free cash flow
- -53.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jul 1, 2026